Similar articles

• Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.

  Levy JH. Levy JH. J Thromb Haemost. 2006 Sep;4(9):1875-8. doi: 10.1111/j.1538-7836.2006.02107.x. Epub 2006 Jun 29. J Thromb Haemost. 2006. PMID: 16805858 Review. No abstract available.
• Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery.

  Guenther CR. Guenther CR. J Cardiothorac Vasc Anesth. 1994 Aug;8(4):471-3. doi: 10.1016/1053-0770(94)90291-7. J Cardiothorac Vasc Anesth. 1994. PMID: 7524719 Review. No abstract available.
• Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.

  Murkin JM. Murkin JM. J Cardiothorac Vasc Anesth. 1994 Aug;8(4):474-6. doi: 10.1016/1053-0770(94)90292-5. J Cardiothorac Vasc Anesth. 1994. PMID: 7524720 Review. No abstract available.
• Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.

  Augoustides JG. Augoustides JG. J Cardiothorac Vasc Anesth. 2007 Apr;21(2):302-4. doi: 10.1053/j.jvca.2007.01.002. J Cardiothorac Vasc Anesth. 2007. PMID: 17418754 No abstract available.
• Suction, salvage, sutures, and potions: blood management post-aprotinin.

  Baker RA. Baker RA. Semin Cardiothorac Vasc Anesth. 2009 Jun;13(2):122-6. doi: 10.1177/1089253209337159. Epub 2009 Jul 17. Semin Cardiothorac Vasc Anesth. 2009. PMID: 19617252